Noboru Suzuki

Title: Noboru Suzuki: Innovator in Antithrombin Research

Introduction

Noboru Suzuki is a prominent inventor based in Ibaraki, Japan. He is known for his significant contributions to the field of biochemistry, particularly in the development of novel therapeutic agents. His work focuses on enhancing antithrombin activity, which plays a crucial role in anticoagulation therapy.

Latest Patents

Noboru Suzuki holds a patent for "Human antithrombin III mutants." This invention describes a novel human antithrombin III (AT III) mutant that exhibits high antithrombin activity in the absence of heparin. It is effective in treating thrombotic disorders as an anticoagulant. The mutant is created by mutating amino acids at the reactive site and the heparin binding site of human AT III using recombinant DNA technology. The invention also includes a method for mass-producing this mutant by incubating a host transformed by an expression vector containing the cDNA of the mutant.

Career Highlights

Noboru Suzuki is associated with Eisai Company, Limited, where he continues to advance his research in the field of anticoagulants. His innovative approach has the potential to significantly impact the treatment of thrombotic disorders.

Collaborations

He has collaborated with notable colleagues, including Hiroyuki Kato and Shinji Yoshitake, to further enhance the research and development of antithrombin therapies.

Conclusion

Noboru Suzuki's work in developing human antithrombin III mutants represents a significant advancement in anticoagulant therapy. His innovative research has the potential to improve treatment options for patients with thrombotic disorders.